0001562180-24-000398.txt : 20240109
0001562180-24-000398.hdr.sgml : 20240109
20240109210756
ACCESSION NUMBER: 0001562180-24-000398
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240105
FILED AS OF DATE: 20240109
DATE AS OF CHANGE: 20240109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duker Jay S.
CENTRAL INDEX KEY: 0001630864
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 24524731
MAIL ADDRESS:
STREET 1: C/O ELEVEN BIOTHERAPEUTICS
STREET 2: 215 1ST ST. #400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-01-05
false
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001630864
Duker Jay S.
C/O EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET
WATERTOWN
MA
02472
true
true
false
false
President and CEO
false
Common Stock
2024-01-06
4
M
false
20793.00
0.00
A
50014.00
D
Common Stock
2024-01-06
4
F
false
6528.00
20.40
D
43486.00
D
Restricted Stock Units
0.00
2024-01-05
4
A
false
90000.00
0.00
A
2034-01-05
Common Stock
90000.00
90000.00
D
Stock Option (Right to Buy)
20.40
2024-01-05
4
A
false
180000.00
0.00
A
2034-01-04
Common Stock
180000.00
180000.00
D
Restricted Stock Units
0.00
2024-01-06
4
M
false
20793.00
0.00
D
2033-06-19
Common Stock
20793.00
41587.00
D
No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
The restricted stock units will vest in three ratable annual installments beginning January 5, 2025.
The option to purchase will vest and become exercisable as follows: 25% at January 5th, 2025 and the remainder ratably, on a monthly basis, over the remaining three years.
The restricted stock units vests in three ratable annual installments beginning January 6, 2024.
/s/ Ron Honig, Attorney-in-Fact
2024-01-09